Skip to main content
    I

    ICL Israel Chemicals Ltd (ICL)

    Official site

    BASIC MATERIALS • AGRICULTURAL INPUTS • NYSE

    $4.41
    -0.11 (-2.54%)

    Market Cap: $6.03B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    ICL Israel Chemicals Ltd (ICL) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect ICL Israel Chemicals (ICL) to earn $0.41 per share in the fiscal year ending Dec 31, 2026, on revenue of $7.95B. Of 4 analysts, 0 rate the stock Buy or Strong Buy, 4 Hold and 0 Sell or Strong Sell, for a consensus of Hold. Over the last 30 days, 0 estimates for the fiscal year ending Dec 31, 2026 were revised up and 3 down.

    Analyst Ratings

    Scoring Strong Buy as 1 and Strong Sell as 5, the 4 ratings average 3.00, inside the Hold band from 2.5 up to 3.5. All 4 rate it Hold.

    RatingAnalystsShare
    Strong Buy00.0%
    Buy00.0%
    Hold4100.0%
    Sell00.0%
    Strong Sell00.0%
    Consensus
    Hold
    Total analysts
    4

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus rises 7.3% and revenue estimates rise 2.9%.

    Fiscal year ending Dec 31, 2026
    $0.41
    EPS consensus, revenue $7.95B
    Fiscal year ending Dec 31, 2027
    $0.44
    EPS consensus, revenue $8.18B

    EPS range

    Revenue range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026$0.41$0.40 to $0.412$7.95B$7.65B to $8.25B4
    Dec 31, 2027$0.44$0.40 to $0.464$8.18B$7.99B to $8.45B4

    Quarterly Estimates

    The EPS consensus rises from $0.09 for the quarter ending Dec 31, 2026 to $0.11 for the quarter ending Mar 31, 2027.

    EPS range

    Quarter endingEPS consensusEPS rangeEPS analysts
    Dec 31, 2026$0.09$0.09 to $0.093
    Mar 31, 2027$0.11$0.10 to $0.122

    Estimate Revisions

    Across the 3 periods below, the last 30 days brought 0 upward and 6 downward EPS revisions. Cuts outnumber raises in every period.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 202603
    Fiscal year ending Dec 31, 202702
    Quarter ending Mar 31, 202701

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has fallen 4.7% from $0.43.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026$0.41$0.41$0.42$0.43$0.43-5.0%
    Fiscal year ending Dec 31, 2027$0.44$0.43$0.44$0.44$0.44+0.5%
    Quarter ending Mar 31, 2027$0.11$0.11$0.11$0.11$0.12-10.4%

    Frequently Asked Questions About ICL

    What is the ICL stock forecast?

    Consensus analyst estimates put ICL Israel Chemicals's EPS at $0.41 for the fiscal year ending Dec 31, 2026, on revenue of $7.95B. The consensus rating from 4 analysts is Hold.

    How do analysts rate ICL stock?

    Of 4 analysts covering ICL Israel Chemicals, 0 rate it Strong Buy, 0 Buy, 4 Hold, 0 Sell and 0 Strong Sell, for a consensus of Hold.

    What EPS do analysts expect from ICL next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $0.41, with estimates from $0.40 to $0.41 from 2 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $0.44, with estimates from $0.40 to $0.46 from 4 analysts.

    What revenue do analysts expect from ICL Israel Chemicals next year?

    For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $7.95B, with estimates from $7.65B to $8.25B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $8.18B, with estimates from $7.99B to $8.45B.

    How many analysts cover ICL?

    4 analysts rate ICL Israel Chemicals stock, and 2 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.